Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Regulus Therapeutics Inc shares valued at $48,693 were sold by Aker Christopher Ray on Jan 13 ’25. At $1.26 per share, Aker Christopher Ray sold 38,547 shares. The insider’s holdings dropped to 54,634 shares worth approximately $52994.979999999996 following the completion of this transaction.
Also, Aker Christopher Ray sold 5,088 shares, netting a total of over 6,427 in proceeds. Following the sale of shares at $1.26 each, the insider now holds 49,546 shares.
Before that, Hagan Joseph P had sold 115,290 shares from its account. In a trade valued at $145,634, the Chief Executive Officer traded Regulus Therapeutics Inc shares for $1.26 each. Upon closing the transaction, the insider’s holdings decreased to 115,290 shares, worth approximately $0.22 million.
As published in their initiating research note from Oppenheimer on August 02, 2024, Regulus Therapeutics Inc [RGLS] has been an Outperform and the price target has been revised to $7. Analysts at Leerink Partners started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid March. As of March 28, 2018, B. Riley FBR Inc. has initiated its “Neutral” rating for RGLS. Earlier on January 05, 2018, Leerink Partners initiated its rating. Their recommendation was “an Outperform” for RGLS stock.
Analyzing RGLS Stock Performance
During the last five days, there has been a drop of approximately -21.77%. Over the course of the year, Regulus Therapeutics Inc shares have dropped approximately -38.61%. Shares of the company reached a 52-week high of $1.6400 on 01/06/25 and a 52-week low of $0.8301 on 01/29/25. A 50-day SMA is recorded $1.4667, while a 200-day SMA reached $1.7507. Nevertheless, trading volume fell to 4.38 million shares from 0.3 million shares the previous day.
Support And Resistance Levels for Regulus Therapeutics Inc (RGLS)
According to the 24-hour chart, there is a support level at 0.8327, which, if violated, would cause prices to drop to 0.6954. In the upper region, resistance lies at 1.1047. The next price resistance is at 1.2394. RSI (Relative Strength Index) is 23.57 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.1396, which suggests the price will decrease in the coming days. Percent R is at 80.57%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
